LBA
Letko, Brosseau & Associates Portfolio holdings
AUM
$5.23B
This Quarter Return
-2.36%
1 Year Return
+15.79%
3 Year Return
+49.62%
5 Year Return
+161.51%
10 Year Return
+219.13%
AUM
$5.17B
AUM Growth
+$5.17B
(-6.2%)
Cap. Flow
-$150M
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
35.54%
Holding
104
New
3
Increased
29
Reduced
47
Closed
4
Top Buys
| 1 |
Rogers Communications
RCI
|
$30.5M |
| 2 |
BCE
BCE
|
$24.3M |
| 3 |
Pfizer
PFE
|
$23.1M |
| 4 |
Moderna
MRNA
|
$17.1M |
| 5 |
GSK
GSK
|
$13.5M |
Top Sells
| 1 |
Celestica
CLS
|
$60M |
| 2 |
Gilead Sciences
GILD
|
$34.9M |
| 3 |
Manulife Financial
MFC
|
$21.7M |
| 4 |
Wells Fargo
WFC
|
$21.4M |
| 5 |
State Street
STT
|
$21.1M |
Sector Composition
| 1 | Financials | 33.6% |
| 2 | Communication Services | 17.84% |
| 3 | Materials | 11.7% |
| 4 | Healthcare | 9.67% |
| 5 | Technology | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares MSCI World ETF
URTH
$5.59B
| $1.15M | 0.02% |
7,400
| – | – |
|
77
SPDR S&P 500 ETF Trust
SPY
$656B
| $1.01M | 0.02% |
1,720
| – | – |
|
78
ING
ING
$71B
| $776K | 0.02% |
49,551
| – | – |
|
79
Vanguard Russell 2000 ETF
VTWO
$12.5B
| $625K | 0.01% |
7,000
| – | – |
|
80
Pembina Pipeline
PBA
$21.9B
| $505K | 0.01% |
13,682
+1,800
| +15% | +$66.5K |
|
81
Duke Energy
DUK
$94.5B
| $442K | 0.01% |
4,100
| – | – |
|
82
Franklin FTSE India ETF
FLIN
$2.32B
| $427K | 0.01% |
+11,275
| New | +$427K |
|
83
Kimberly-Clark
KMB
$42.5B
| $396K | 0.01% |
3,025
| – | – |
|
|
ALTM
84
DELISTED
Arcadium Lithium plc
ALTM
| $376K | 0.01% |
73,250
| – | – |
|
85
Fortis
FTS
$24.9B
| $353K | 0.01% |
8,500
| – | – |
|
86
Vale
VALE
$43.6B
| $325K | 0.01% |
36,650
| – | – |
|
87
MeiraGTx Holdings
MGTX
$590M
| $276K | 0.01% |
45,300
| – | – |
|
88
Microsoft
MSFT
$3.76T
| $269K | 0.01% |
638
| – | – |
|
89
ARS Pharmaceuticals
SPRY
$1.08B
| $261K | 0.01% |
24,700
| – | – |
|
90
MetLife
MET
$53.6B
| $237K | ﹤0.01% |
2,900
| – | – |
|
91
Albemarle
ALB
$9.43B
| $213K | ﹤0.01% |
2,475
| – | – |
|
92
Alphabet (Google) Class A
GOOGL
$2.79T
| $207K | ﹤0.01% |
+1,092
| New | +$207K |
|
93
Mineralys Therapeutics
MLYS
$1.94B
| $203K | ﹤0.01% |
16,500
+5,100
| +45% | +$62.8K |
|
94
Aura Biosciences
AURA
$394M
| $174K | ﹤0.01% |
21,200
| – | – |
|
95
Pliant Therapeutics
PLRX
$105M
| $137K | ﹤0.01% |
10,400
| – | – |
|
96
TScan Therapeutics
TCRX
$106M
| $110K | ﹤0.01% |
36,200
+15,500
| +75% | +$47.1K |
|
97
Aldeyra Therapeutics
ALDX
$350M
| $86.3K | ﹤0.01% |
+17,300
| New | +$86.3K |
|
98
89bio
ETNB
$1.37B
| $83.7K | ﹤0.01% |
10,700
| – | – |
|
99
ProKidney
PROK
$319M
| $26.9K | ﹤0.01% |
15,900
| – | – |
|
100
Outset Medical
OM
$245M
| $15K | ﹤0.01% |
13,550
| – | – |
|